Published in Ann Neurol on July 01, 2007
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
The pathobiology of vascular dementia. Neuron (2013) 3.07
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol (2009) 2.87
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron (2010) 2.37
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol (2008) 2.10
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Trajectory of Cognitive Decline After Incident Stroke. JAMA (2015) 1.75
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement (2011) 1.71
Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr (2010) 1.67
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain (2013) 1.64
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology (2008) 1.59
Mediterranean diet and late-life cognitive impairment: a taste of benefit. JAMA (2009) 1.55
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain (2012) 1.47
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain (2012) 1.40
Where vascular meets neurodegenerative disease. Stroke (2010) 1.35
Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases. Alzheimer Dis Assoc Disord (2009) 1.34
Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study. BMC Med (2011) 1.33
Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry (2012) 1.22
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol (2008) 1.16
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease. Acta Neuropathol (2013) 1.15
Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol Commun (2013) 1.15
Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2012) 1.15
Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. J Cereb Blood Flow Metab (2013) 1.13
Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol (2010) 1.13
Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One (2011) 1.10
Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment. Neuroimage (2012) 1.07
Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke (2015) 1.07
Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis (2012) 1.06
Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? Am J Cardiovasc Dis (2013) 1.05
The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol (2010) 1.05
Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03
Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna) (2009) 1.03
Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc (2011) 0.97
Antemortem MRI findings associated with microinfarcts at autopsy. Neurology (2014) 0.93
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener (2011) 0.92
Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) (2014) 0.92
Relationship between late-life hypertension, blood pressure, and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2011) 0.91
Blood platelets in the progression of Alzheimer's disease. PLoS One (2014) 0.89
The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease. JAMA Neurol (2015) 0.87
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Res (2012) 0.86
Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med (2013) 0.85
In vivo quantification of white matter microstructure for use in aging: a focus on two emerging techniques. Am J Geriatr Psychiatry (2013) 0.84
Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging (2015) 0.82
Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging (2014) 0.82
An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging. Dement Geriatr Cogn Disord (2010) 0.82
Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1. Neurobiol Aging (2008) 0.81
Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes. Neurobiol Aging (2015) 0.81
Cooccurrence of vascular risk factors and late-life white-matter integrity changes. Neurobiol Aging (2015) 0.79
Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia. Neurology (2015) 0.79
Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study. Alzheimers Dement (2016) 0.79
Cardiovascular prevention of cognitive decline. Cardiol Res Pract (2011) 0.78
Datasets for special series on cognitive reserve. J Int Neuropsychol Soc (2011) 0.78
The inclusion of cognition in vascular risk factor clinical practice guidelines. Clin Interv Aging (2009) 0.78
Brain arterial aging and its relationship to Alzheimer dementia. Neurology (2016) 0.78
Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging (2015) 0.78
Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab (2016) 0.77
Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2012) 0.77
Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns. Neuropsychol Rev (2014) 0.77
AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol (2012) 0.77
Association of lower hemoglobin level and neuropathology in community-dwelling older persons. J Alzheimers Dis (2012) 0.77
Balanced bifrontal transcranial direct current stimulation enhances working memory in adults with high-functioning autism: a sham-controlled crossover study. Mol Autism (2017) 0.77
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta (2015) 0.76
Clinical-pathologic correlations in vascular cognitive impairment and dementia. Biochim Biophys Acta (2015) 0.76
Dementia: A link between microbial infection and cognition? Nat Rev Neurol (2013) 0.76
Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygote. Dement Geriatr Cogn Disord (2010) 0.75
Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimers Dement (2016) 0.75
Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP. Front Behav Neurosci (2015) 0.75
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA (2002) 6.18
Charting a dynamic DNA methylation landscape of the human genome. Nature (2013) 5.80
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol (2003) 4.37
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc (2005) 3.68
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest (2012) 3.65
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry (2007) 3.44
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA (2002) 3.19
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology (2006) 3.00
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron (2008) 2.99
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging (2005) 2.79
Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol (2013) 2.78
Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science (2011) 2.66
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology (2013) 2.59
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51
Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry (2007) 2.41
Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol (2005) 2.38
Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol (2002) 2.27
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med (2007) 2.27
Association between late-life social activity and motor decline in older adults. Arch Intern Med (2009) 2.26
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol (2006) 2.17
A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol (2015) 2.16
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry (2005) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry (2010) 2.07
Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology (2006) 2.07
Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry (2007) 2.02
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol (2011) 2.02
Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry (2008) 1.98
Vitamin E and cognitive decline in older persons. Arch Neurol (2002) 1.98
Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol (2006) 1.98
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Neuroticism, extraversion, and mortality in a defined population of older persons. Psychosom Med (2005) 1.96
Racial disparities in disability: recent evidence from self-reported and performance-based disability measures in a population-based study of older adults. J Gerontol B Psychol Sci Soc Sci (2005) 1.94
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol (2002) 1.92
Racial differences in perceived discrimination in a community population of older blacks and whites. J Aging Health (2004) 1.91
Terminal cognitive decline: accelerated loss of cognition in the last years of life. Psychosom Med (2007) 1.85
Personality and mortality in old age. J Gerontol B Psychol Sci Soc Sci (2004) 1.84
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol (2002) 1.82
Purpose in life is associated with mortality among community-dwelling older persons. Psychosom Med (2009) 1.81
Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis (2013) 1.80
ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord (2006) 1.80
Perceived discrimination and mortality in a population-based study of older adults. Am J Public Health (2008) 1.79
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol (2012) 1.79
Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc (2010) 1.78
Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons. Sleep (2013) 1.76
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology (2013) 1.76